Skip to main content
. 2021 Oct 8;8:740154. doi: 10.3389/fmed.2021.740154

Figure 1.

Figure 1

Prevalence of anti-CMV-specific antibodies in healthy controls and IIM. Higher levels of IgG and IgM antibodies against CMV were detected in IIM patients than in healthy controls (p < 0.05). Levels of CMV-IgM and CMV-IgG in IIM patients were significantly increased in healthy individuals compared with IIM patients [CMV-IgG: 6 U/mL, IQR (5–11) U/mL vs. 14 U/mL, IQR (89–146) U/mL, CMV-IgM: 0 U/mL vs. 105 U/mL, IQR (98–164) U/mL, both p < 0.05].